What is the rationale for treating non-diabetic adults with CKD ND and urine albumin excretion of 30 to 300 mg per 24 hours?
The rationale for treating non-diabetic adults with CKD ND and urine albumin excretion of 30 to 300 mg per 24 hours is to reduce the risk of CVD and CKD progression. Urine albumin level of 30 to 300 mg per 24 hours (microalbuminuria) is a risk factor for CVD and CKD progression. RCTs suggest that a BP r130/80 mm Hg may reduce progression of CKD. Patients with microalbuminuria are at high risk for progression of CKD as well as development of CVD.